213 related articles for article (PubMed ID: 37424015)
1. Enhanced tyrosine sulfation is associated with chronic kidney disease-related atherosclerosis.
Dai D; Zhu Z; Han H; Xu T; Feng S; Zhang W; Ding F; Zhang R; Zhu J
BMC Biol; 2023 Jul; 21(1):151. PubMed ID: 37424015
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Analysis of N-Terminal Chemokine Receptor Sulfopeptides Using Tyrosylprotein Sulfotransferase Enzymes.
Seibert C; Sanfiz A; Sakmar TP; Veldkamp CT
Methods Enzymol; 2016; 570():357-88. PubMed ID: 26921955
[TBL] [Abstract][Full Text] [Related]
3. Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice.
Westmuckett AD; Moore KL
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1730-6. PubMed ID: 19679829
[TBL] [Abstract][Full Text] [Related]
4. Targeted disruption of tyrosylprotein sulfotransferase-2, an enzyme that catalyzes post-translational protein tyrosine O-sulfation, causes male infertility.
Borghei A; Ouyang YB; Westmuckett AD; Marcello MR; Landel CP; Evans JP; Moore KL
J Biol Chem; 2006 Apr; 281(14):9423-31. PubMed ID: 16469738
[TBL] [Abstract][Full Text] [Related]
5. Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody.
Hoffhines AJ; Damoc E; Bridges KG; Leary JA; Moore KL
J Biol Chem; 2006 Dec; 281(49):37877-87. PubMed ID: 17046811
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence.
Seibert C; Cadene M; Sanfiz A; Chait BT; Sakmar TP
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11031-6. PubMed ID: 12169668
[TBL] [Abstract][Full Text] [Related]
7. Tyrosylprotein sulfotransferase-2 expression is required for sulfation of RNase 9 and Mfge8 in vivo.
Hoffhines AJ; Jen CH; Leary JA; Moore KL
J Biol Chem; 2009 Jan; 284(5):3096-3105. PubMed ID: 19047058
[TBL] [Abstract][Full Text] [Related]
8. [Regulation of tyrosylprotein sulfotransferases activity by sulfotyrosine].
Gao JM; Feng QP; Zuo J; Fang FD; Jiang L; Guo ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):241-5. PubMed ID: 17536277
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine sulfation of native mouse Psgl-1 is required for optimal leukocyte rolling on P-selectin in vivo.
Westmuckett AD; Thacker KM; Moore KL
PLoS One; 2011; 6(5):e20406. PubMed ID: 21633705
[TBL] [Abstract][Full Text] [Related]
10. Lack of tyrosylprotein sulfotransferase-2 activity results in altered sperm-egg interactions and loss of ADAM3 and ADAM6 in epididymal sperm.
Marcello MR; Jia W; Leary JA; Moore KL; Evans JP
J Biol Chem; 2011 Apr; 286(15):13060-70. PubMed ID: 21339297
[TBL] [Abstract][Full Text] [Related]
11. Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.
Seibert C; Veldkamp CT; Peterson FC; Chait BT; Volkman BF; Sakmar TP
Biochemistry; 2008 Oct; 47(43):11251-62. PubMed ID: 18834145
[TBL] [Abstract][Full Text] [Related]
12. Structural and energetic determinants of tyrosylprotein sulfotransferase sulfation specificity.
Nedumpully-Govindan P; Li L; Alexov EG; Blenner MA; Ding F
Bioinformatics; 2014 Aug; 30(16):2302-9. PubMed ID: 24794930
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins.
Stone MJ; Chuang S; Hou X; Shoham M; Zhu JZ
N Biotechnol; 2009 Jun; 25(5):299-317. PubMed ID: 19658209
[TBL] [Abstract][Full Text] [Related]
14. New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors.
Byrne DP; Li Y; Ngamlert P; Ramakrishnan K; Eyers CE; Wells C; Drewry DH; Zuercher WJ; Berry NG; Fernig DG; Eyers PA
Biochem J; 2018 Aug; 475(15):2435-2455. PubMed ID: 29934490
[TBL] [Abstract][Full Text] [Related]
15. Early postnatal pulmonary failure and primary hypothyroidism in mice with combined TPST-1 and TPST-2 deficiency.
Westmuckett AD; Hoffhines AJ; Borghei A; Moore KL
Gen Comp Endocrinol; 2008 Mar; 156(1):145-53. PubMed ID: 18243191
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the SLC35B2-TPST2 Axis of Tyrosine Sulfation Attenuates the Growth and Metastasis of Pancreatic Ductal Adenocarcinom.
Cai X; Li S; Zeng X; Xu M; Wang Z; Singhi AD; Tang D; Li S; Yates NA; Yang D; Xie W
Cell Mol Gastroenterol Hepatol; 2023; 16(3):473-495. PubMed ID: 37192689
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1.
Tanaka S; Nishiyori T; Kojo H; Otsubo R; Tsuruta M; Kurogi K; Liu MC; Suiko M; Sakakibara Y; Kakuta Y
Sci Rep; 2017 Aug; 7(1):8776. PubMed ID: 28821720
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland hypofunction in tyrosylprotein sulfotransferase-2 knockout mice is due to primary hypothyroidism.
Westmuckett AD; Siefert JC; Tesiram YA; Pinson DM; Moore KL
PLoS One; 2013; 8(8):e71822. PubMed ID: 23951251
[TBL] [Abstract][Full Text] [Related]
19. Protein tyrosine sulfation, 1993--an update.
Niehrs C; Beisswanger R; Huttner WB
Chem Biol Interact; 1994 Jun; 92(1-3):257-71. PubMed ID: 8033259
[TBL] [Abstract][Full Text] [Related]
20. ADY tripeptide is a minimum sequence for Tyrosylprotein sulfotransferases 1 and 2 substrate recognition.
Hasegawa Y; Tonsho S; Nakazawa T; Kainuma T; Kagasaki K; Sakurai S; Kitagawa K; Asada S
Biochem Biophys Res Commun; 2023 Oct; 676():73-77. PubMed ID: 37490834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
